1. 19 Identification and evaluation of novel protein biomarkers for atrial fibrillation. (6th October 2022) Authors: Tonry, C; Russell-Hallinan, A; Glezeva, N; Collier, P; McDonald, K; Ledwidge, M; Collins, BC; Watson, C Journal: Heart Issue: Volume 108(2022)Supplement 3 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 26 Using combination of high-fat diet and high-dose streptozotocin to develop an in vivo model of diabetic cardiomyopathy. (16th October 2019) Authors: Kerrigan, L; Edgar, K; Russell-Hallinan, A; Grieve, D; Watson, C Journal: Heart Issue: Volume 105(2019)Supplement 7 Page Start: A22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 36 Hypoxia induces gene-specific epigenetic modifications that promotes a hyperactive pro-fibrotic phenotype in human cardiac fibroblasts. (16th October 2019) Authors: Russell-Hallinan, A; Glezeva, N; Moran, B; Das, S; Ledwidge, M; McDonald, K; Baugh, J; Watson, C Journal: Heart Issue: Volume 105(2019)Supplement 7 Page Start: A30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 65 Elevated levels of cathepsin S is associated with inflammation and pathological remodelling in heart failure with preserved ejection fraction. (16th October 2019) Authors: Russell-Hallinan, A; Glezeva, N; McDonald, I; Cooke, G; Ledwidge, M; McDonald, K; Burden, R; Watson, C Journal: Heart Issue: Volume 105(2019)Supplement 7 Page Start: A53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗